Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.

Varanasi PR, Ogonek J, Luther S, Dammann E, Stadler M, Ganser A, Borchers S, Hambach L, Weissinger EM.

PLoS One. 2019 Mar 19;14(3):e0213739. doi: 10.1371/journal.pone.0213739. eCollection 2019.

2.

Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.

Sellmann L, Rabe K, Bünting I, Dammann E, Göhring G, Ganser A, Stadler M, Weissinger EM, Hambach L.

Bone Marrow Transplant. 2018 Nov;53(11):1457-1465. doi: 10.1038/s41409-018-0176-7. Epub 2018 May 2.

PMID:
29720704
3.

Biomarkers in chronic graft-versus-host disease: quo vadis?

Wolff D, Greinix H, Lee SJ, Gooley T, Paczesny S, Pavletic S, Hakim F, Malard F, Jagasia M, Lawitschka A, Hansen JA, Pulanic D, Holler E, Dickinson A, Weissinger E, Edinger M, Sarantopoulos S, Schultz KR.

Bone Marrow Transplant. 2018 Jul;53(7):832-837. doi: 10.1038/s41409-018-0092-x. Epub 2018 Jan 24.

4.

Predicting death in patients with acute graft-versus-host disease after reduced-intensity conditioning.

Weissinger EM, Ganser A.

Lancet Haematol. 2017 Sep;4(9):e400-e401. doi: 10.1016/S2352-3026(17)30142-4. No abstract available.

PMID:
28863797
5.

miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation.

Verma K, Jyotsana N, Buenting I, Luther S, Pfanne A, Thum T, Ganser A, Heuser M, Weissinger EM, Hambach L.

PLoS One. 2017 Aug 30;12(8):e0183828. doi: 10.1371/journal.pone.0183828. eCollection 2017.

6.

Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.

Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Koehl U, Koenecke C, Weissinger EM, Hambach L.

J Immunol. 2017 Jul 15;199(2):792-805. doi: 10.4049/jimmunol.1601992. Epub 2017 Jun 19.

7.

Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation.

Ogonek J, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Borchers S, Koehl U, Weissinger EM, Hambach L.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1046-1053. doi: 10.1016/j.bbmt.2017.03.027. Epub 2017 Mar 23.

8.

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G.

Front Immunol. 2017 Jan 16;7:660. doi: 10.3389/fimmu.2016.00660. eCollection 2016. Review.

9.

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.

Neuenhahn M, Albrecht J, Odendahl M, Schlott F, Dössinger G, Schiemann M, Lakshmipathi S, Martin K, Bunjes D, Harsdorf S, Weissinger EM, Menzel H, Verbeek M, Uharek L, Kröger N, Wagner E, Kobbe G, Schroeder T, Schmitt M, Held G, Herr W, Germeroth L, Bonig H, Tonn T, Einsele H, Busch DH, Grigoleit GU.

Leukemia. 2017 Oct;31(10):2161-2171. doi: 10.1038/leu.2017.16. Epub 2017 Jan 16.

PMID:
28090089
10.

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, Weissinger E.

Front Immunol. 2016 Nov 17;7:507. eCollection 2016. Review.

11.

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications.

Reis M, Ogonek J, Qesari M, Borges NM, Nicholson L, Preußner L, Dickinson AM, Wang XN, Weissinger EM, Richter A.

Front Immunol. 2016 Nov 14;7:500. eCollection 2016. Review.

12.

Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Juric MK, Ghimire S, Ogonek J, Weissinger EM, Holler E, van Rood JJ, Oudshoorn M, Dickinson A, Greinix HT.

Front Immunol. 2016 Nov 9;7:470. eCollection 2016. Review.

13.

The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.

Weissinger EM, Human C, Metzger J, Hambach L, Wolf D, Greinix HT, Dickinson AM, Mullen W, Jonigk D, Kuzmina Z, Kreipe H, Schweier P, Böhm O, Türüchanow I, Ihlenburg-Schwarz D, Raad J, Durban A, Schiemann M, Könecke C, Diedrich H, Holler E, Beutel G, Krauter J, Ganser A, Stadler M.

Leukemia. 2017 Mar;31(3):654-662. doi: 10.1038/leu.2016.259. Epub 2016 Sep 28.

PMID:
27677743
14.

Comparison of Land, Water, and Energy Requirements of Lettuce Grown Using Hydroponic vs. Conventional Agricultural Methods.

Barbosa GL, Gadelha FD, Kublik N, Proctor A, Reichelm L, Weissinger E, Wohlleb GM, Halden RU.

Int J Environ Res Public Health. 2015 Jun 16;12(6):6879-91. doi: 10.3390/ijerph120606879.

15.

Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells.

Weissinger EM, Borchers S, Silvani A, Provasi E, Radrizzani M, Beckmann IK, Benati C, Schmidtke J, Kuehnau W, Schweier P, Luther S, Fernandez-Munoz I, Beutel G, Ciceri F, Bonini C, Ganser A, Hertenstein B, Stadler M.

Front Pharmacol. 2015 Apr 23;6:76. doi: 10.3389/fphar.2015.00076. eCollection 2015.

16.

Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.

van der Torren CR, van Hensbergen Y, Luther S, Aghai Z, Rychnavská ZS, Slot M, Scherjon S, Kröger N, Ganser A, Weissinger EM, Goulmy E, Hambach L.

PLoS One. 2015 Mar 16;10(3):e0119595. doi: 10.1371/journal.pone.0119595. eCollection 2015.

17.

Urinary proteomics employing capillary electrophoresis coupled to mass spectrometry in the monitoring of patients after stem cell transplantation.

Weissinger EM, Mullen W, Albalat A.

Methods Mol Biol. 2014;1109:293-306. doi: 10.1007/978-1-4614-9437-9_15.

PMID:
24473789
18.

Multimer monitoring of CMV-specific T cells in research and in clinical applications.

Borchers S, Ogonek J, Varanasi PR, Tischer S, Bremm M, Eiz-Vesper B, Koehl U, Weissinger EM.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):201-12. doi: 10.1016/j.diagmicrobio.2013.11.007. Epub 2013 Nov 15. Review.

PMID:
24331953
19.

Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.

Bunse CE, Borchers S, Varanasi PR, Tischer S, Figueiredo C, Immenschuh S, Kalinke U, Köhl U, Goudeva L, Maecker-Kolhoff B, Ganser A, Blasczyk R, Weissinger EM, Eiz-Vesper B.

PLoS One. 2013 Dec 4;8(12):e77925. doi: 10.1371/journal.pone.0077925. eCollection 2013.

20.

Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.

Weissinger EM, Metzger J, Dobbelstein C, Wolff D, Schleuning M, Kuzmina Z, Greinix H, Dickinson AM, Mullen W, Kreipe H, Hamwi I, Morgan M, Krons A, Tchebotarenko I, Ihlenburg-Schwarz D, Dammann E, Collin M, Ehrlich S, Diedrich H, Stadler M, Eder M, Holler E, Mischak H, Krauter J, Ganser A.

Leukemia. 2014 Apr;28(4):842-52. doi: 10.1038/leu.2013.210. Epub 2013 Jul 11.

PMID:
23842427
21.

Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation.

Borchers S, Weissinger EM, Pabst B, Ganzenmueller T, Dammann E, Luther S, Diedrich H, Ganser A, Stadler M.

Transpl Infect Dis. 2013 Dec;15(6):627-33. doi: 10.1111/tid.12101. Epub 2013 Jun 19.

PMID:
23782397
22.

Donor Vδ1+ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL.

Prinz I, Thamm K, Port M, Weissinger EM, Stadler M, Gabaev I, Jacobs R, Ganser A, Koenecke C.

Exp Hematol Oncol. 2013 May 11;2(1):14. doi: 10.1186/2162-3619-2-14.

23.

Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

Borchers S, Bremm M, Lehrnbecher T, Dammann E, Pabst B, Wölk B, Esser R, Yildiz M, Eder M, Stadler M, Bader P, Martin H, Jarisch A, Schneider G, Klingebiel T, Ganser A, Weissinger EM, Koehl U.

PLoS One. 2012;7(12):e50248. doi: 10.1371/journal.pone.0050248. Epub 2012 Dec 13. Erratum in: PLoS One. 2013;8(4). doi: 10.1371/annotation/43e9b84c-fbe3-4b39-88c8-1cde34b0afea.

24.

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

Daenthanasanmak A, Salguero G, Borchers S, Figueiredo C, Jacobs R, Sundarasetty BS, Schneider A, Schambach A, Eiz-Vesper B, Blasczyk R, Weissinger EM, Ganser A, Stripecke R.

Vaccine. 2012 Jul 20;30(34):5118-31. doi: 10.1016/j.vaccine.2012.05.063. Epub 2012 Jun 9.

25.

Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.

Thol F, Yun H, Sonntag AK, Damm F, Weissinger EM, Krauter J, Wagner K, Morgan M, Wichmann M, Göhring G, Bug G, Ottmann O, Hofmann WK, Schambach A, Schlegelberger B, Haferlach T, Bowen D, Mills K, Ganser A, Heuser M.

Ann Hematol. 2012 Aug;91(8):1221-33. doi: 10.1007/s00277-012-1457-7. Epub 2012 Apr 10.

PMID:
22488406
26.

Intramedullary spinal cord implantation of human CD34+ umbilical cord-derived cells in ALS.

Cordes AL, Jahn K, Hass R, Schwabe K, Weissinger EM, Ganser A, Götz F, Dengler R, Krauss JK, Petri S.

Amyotroph Lateral Scler. 2011 Sep;12(5):325-30. doi: 10.3109/17482968.2011.580850. Epub 2011 Aug 3.

PMID:
21812628
27.

Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

Thol F, Friesen I, Damm F, Yun H, Weissinger EM, Krauter J, Wagner K, Chaturvedi A, Sharma A, Wichmann M, Göhring G, Schumann C, Bug G, Ottmann O, Hofmann WK, Schlegelberger B, Heuser M, Ganser A.

J Clin Oncol. 2011 Jun 20;29(18):2499-506. doi: 10.1200/JCO.2010.33.4938. Epub 2011 May 16.

PMID:
21576631
28.

Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.

Lankisch TO, Metzger J, Negm AA, Vosskuhl K, Schiffer E, Siwy J, Weismüller TJ, Schneider AS, Thedieck K, Baumeister R, Zürbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J.

Hepatology. 2011 Mar;53(3):875-84. doi: 10.1002/hep.24103. Epub 2011 Jan 3.

PMID:
21374660
29.

Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation.

Borchers S, Provasi E, Silvani A, Radrizzani M, Benati C, Dammann E, Krons A, Kontsendorn J, Schmidtke J, Kuehnau W, von Neuhoff N, Stadler M, Ciceri F, Bonini C, Ganser A, Hertenstein B, Weissinger EM.

Hum Gene Ther. 2011 Jul;22(7):829-41. doi: 10.1089/hum.2010.162. Epub 2011 Mar 30.

30.

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.

Metzger J, Kirsch T, Schiffer E, Ulger P, Mentes E, Brand K, Weissinger EM, Haubitz M, Mischak H, Herget-Rosenthal S.

Kidney Int. 2010 Dec;78(12):1252-62. doi: 10.1038/ki.2010.322. Epub 2010 Sep 8.

31.

Recommendations for biomarker identification and qualification in clinical proteomics.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Sci Transl Med. 2010 Aug 25;2(46):46ps42. doi: 10.1126/scitranslmed.3001249.

PMID:
20739680
32.

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM, Mohty M, Or R, Maschan M, Schumm M, Hamprecht K, Handgretinger R, Lang P, Einsele H.

Blood. 2010 Nov 18;116(20):4360-7. doi: 10.1182/blood-2010-01-262089. Epub 2010 Jul 12.

33.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

34.

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

Thol F, Weissinger EM, Krauter J, Wagner K, Damm F, Wichmann M, Göhring G, Schumann C, Bug G, Ottmann O, Hofmann WK, Schlegelberger B, Ganser A, Heuser M.

Haematologica. 2010 Oct;95(10):1668-74. doi: 10.3324/haematol.2010.025494. Epub 2010 May 21.

35.

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.

Weissinger EM, Dickinson AM.

Cancer Treat Res. 2009;144:95-129. doi: 10.1007/978-0-387-78580-6_5. Review. No abstract available.

PMID:
19779872
36.

Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry.

Weissinger EM, Mischak H, Kontsendorn J, Hahn A, Hahn N, Morgan M, Ganser A.

Mini Rev Med Chem. 2009 May;9(5):627-3. Review.

PMID:
19456293
37.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Ciceri F, Bonini C, Stanghellini MT, Bondanza A, Traversari C, Salomoni M, Turchetto L, Colombi S, Bernardi M, Peccatori J, Pescarollo A, Servida P, Magnani Z, Perna SK, Valtolina V, Crippa F, Callegaro L, Spoldi E, Crocchiolo R, Fleischhauer K, Ponzoni M, Vago L, Rossini S, Santoro A, Todisco E, Apperley J, Olavarria E, Slavin S, Weissinger EM, Ganser A, Stadler M, Yannaki E, Fassas A, Anagnostopoulos A, Bregni M, Stampino CG, Bruzzi P, Bordignon C.

Lancet Oncol. 2009 May;10(5):489-500. doi: 10.1016/S1470-2045(09)70074-9. Epub 2009 Apr 1.

PMID:
19345145
38.

Proteomics studies after hematopoietic stem cell transplantation.

Weissinger EM, Zürbig P, Ganser A.

Methods Mol Biol. 2009;506:437-52. doi: 10.1007/978-1-59745-409-4_29.

PMID:
19110643
39.

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments.

Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF.

Mass Spectrom Rev. 2009 Sep-Oct;28(5):703-24. doi: 10.1002/mas.20205. Review.

40.

Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.

Koehl U, Dirkwinkel E, Koenig M, Erben S, Soerensen J, Bader P, Doerr HW, Preiser W, Weissinger E, Klingebiel T, Martin H, Lehrnbecher T.

Klin Padiatr. 2008 Nov-Dec;220(6):348-52. doi: 10.1055/s-0028-1086029. Epub 2008 Oct 23.

PMID:
18949669
41.

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Proteomics Clin Appl. 2008 Jul 10;2(7-8):964.

42.

Application of proteomics to posttransplantational follow-up.

Weissinger EM, Mischak H.

Methods Mol Med. 2007;134:217-28.

PMID:
17666753
43.

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zürbig P, Kellmann M, Ganser A.

Blood. 2007 Jun 15;109(12):5511-9. Epub 2007 Mar 5.

44.

Clinical proteomics: A need to define the field and to begin to set adequate standards.

Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, Neusuess C, Novak J, Peter K, Rossing K, Schanstra J, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, Van Eyk JE, Yamamoto T.

Proteomics Clin Appl. 2007 Feb;1(2):148-56. doi: 10.1002/prca.200600771. Epub 2007 Jan 22.

PMID:
21136664
45.

Going from genes to proteins in myelodysplastic syndromes.

Ganser A, Morgan MA, Weissinger EM.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1109-10. Epub 2007 Jan 19. No abstract available.

46.

Value of proteomics applied to the follow-up in stem cell transplantation.

Weissinger EM, Mischak H, Ganser A, Hertenstein B.

Ann Hematol. 2006 Apr;85(4):205-11. Epub 2006 Feb 7. Review.

PMID:
16463156
47.

Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.

Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drüeke TB, Lacour B, Massy ZA.

Proteomics. 2006 Feb;6(3):993-1000.

PMID:
16372263
48.

Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis.

Weissinger EM, Hertenstein B, Mischak H, Ganser A.

Expert Rev Proteomics. 2005 Oct;2(5):639-47. Review.

PMID:
16209644
49.

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.

Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H.

Kidney Int. 2005 Jun;67(6):2313-20.

50.

Proteomics: a novel tool to unravel the patho-physiology of uraemia.

Weissinger EM, Kaiser T, Meert N, De Smet R, Walden M, Mischak H, Vanholder RC.

Nephrol Dial Transplant. 2004 Dec;19(12):3068-77. Epub 2004 Oct 19.

PMID:
15494356

Supplemental Content

Loading ...
Support Center